Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

FAPON

Fapon is a global IVD raw materials & one-stop solutions company offering 700+ reagent raw materials for the applicat... read more Featured Products: More products

Download Mobile App





Fapon Presents AI-Driven Diagnostic Innovation and Advanced Alzheimer's Disease Blood Testing Solutions

By LabMedica International staff writers
Posted on 18 Nov 2025

Fapon, a global leader in life sciences, is participating at MEDICA 2025 from November 17 to 20 in Düsseldorf, Germany, where it is underscoring its strengths in diagnostic innovation. More...

At booth A81 in Hall 3, the company is presenting how AI-driven technologies are advancing diagnostic R&D and unveiling a range of IVD solutions and new products, with particular emphasis on its state-of-the-art blood testing solutions for Alzheimer’s disease (AD).

Fapon’s “AI-driven + closed-loop dry and wet experimentation” R&D model greatly enhances the efficiency of biomarker discovery and the development of diagnostic solutions. A standout achievement of this approach is the company’s advanced AD blood testing solution. Designed to support IVD manufacturers, it offers a complete suite of raw materials and bulk reagents for core Alzheimer’s biomarkers, including p-tau 217, p-tau 181, amyloid beta 40, amyloid beta 42, GFAP, NfL, and APOE4. These innovative materials deliver high sensitivity and specificity, with strong concordance to predicate kits and established clinical tests, enabling the development of more precise and reliable AD assays.

Fapon is also presenting its full suite of one-stop IVD solutions, encompassing raw materials, reagent development services, and open-platform instruments. A highlight is the chemiluminescence one-stop solution, which integrates high-performance core materials, a panel of more than 70 self-developed assays, and the versatile Shine i-Series CLIA analyzers encompassing low to ultra-high throughput to address testing demands across diverse clinical settings. Additionally, the Shine mT8000 Fully Automatic Clinical Chemistry and Immunoassay System provides end-to-end workflow automation within a compact, space-efficient footprint of just 5 m².

Fapon is also showcasing its portfolio of high-performance IVD raw materials, including recombinant quality-control and calibrator components for key disease markers such as RF, HbA1c, HIV/HIV-P24, HCV, TP, HBV, and ToRCH. The company is further highlighting its animal-origin-free IgG blockers and LAMP solutions designed for rapid molecular testing.

Related Links:
Fapon Biotech


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.